Skip to content

Home
About
Testimonials
News
Contact

New $50M VC fund to focus solely on blood and cell therapies – FierceBiotech

Posted on May 12, 2023 by admin

New $50M VC fund to focus solely on blood and cell therapies FierceBiotech

Bookmark the permalink.

Post navigation

← AI Startup Rewind Gets 170 Offers—and $350 Million Valuation in Unusual Fundraising – The Information

New Indianapolis venture capital firm launches first $20M fund – IndyStar →

Search for:

Recent Posts

US appeals court blocks venture capital fund’s grant program for Black women – Reuters
U.S. venture capital firm 8VC targets Japan’s defense industry – Nikkei Asia
Exclusive: VC firms working with D.C. to “self-regulate” AI startup investing – Axios
Peak XV Partners makes modest exit from legacy tech bet – VCCircle
Rishi Sunak’s wife Akshata Murty to wind down venture capital fund – The Guardian
To Win the Tech Race with China, Unleash the Venture Capitalists – TIME
All venture funds use the ‘2 and 20’ fee structure, right? Not really – TechCrunch
US judge refuses to block venture capital fund’s grants for Black women – Reuters
T-Mobile’s corporate venture arm reveals second fund to invest in AI, edge computing, and more – GeekWire
Judge refuses to immediately block grant program for Black women entrepreneurs – Tulsa World

Singapore Office:
21 Bukit Batok Crescent
#09-79 WCEGA Tower
Singapore 658065

Korea Office:
1432 Seocho LG Eclat Banpo-daero
14-gil 71, Seocho-gu Seoul,
Republic of Korea

For Regional Support:
support@leconasia.com

For Sales & Marketing:
sales@leconasia.com

LECON ASIA
Copyrights © 2015
All Rights Reserved

www.leconasia.com

Zerif Lite developed by ThemeIsle